Additionally, the tumor pharmacokinetic DCE-MRI perfusion parameters in patients with OC are negatively correlated with the expression level of HIF-1α, which can be used to screen the tumor characteristics of OC and help clinicians choose the best treatment options [186]. The gene discussed is HIF1A; the disease is neoplasm.